Related Experiment Video
Updated: Apr 26, 2026

Quantification of Mouse Heart Left Ventricular Function, Myocardial Strain, and Hemodynamic Forces by Cardiovascular Magnetic Resonance Imaging
Published on: May 24, 2021
Cardiac structure and function in Cushing's syndrome: a cardiac magnetic resonance imaging study
Peter Kamenický1, Alban Redheuil, Charles Roux
1Faculté de Médecine (P.K., S.S., S.B., J.Y., P.C.), Univ Paris-Sud, F-94276 Le Kremlin Bicêtre, France; Faculté de Médecine (A.R., N.K.), Sorbonne Universités, Université Pierre et Marie Curie Univ Paris 06, F75006 Paris, France; Faculté de Médecine (E.M.), Université Paris Descartes, F75006 Paris, France; Service d'Endocrinologie et des Maladies de la Reproduction (P.K., S.S., J.Y., P.C.) and Service de Pharmacogénétique (S.B.), Biochimie Moléculaire et Hormonologie, Hôpital de Bicêtre, Assistance Publique-Hôpitaux de Paris, F-94275 Le Kremlin Bicêtre, France; Département d'Imagerie Cardiovasculaire (A.R.) and Service d'Endocrinologie (C.J.), Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, F75013 Paris, France; Service de Radiologie Cardiovasculaire (C.R., L.M., A.A., Z.R., E.M.), Hôpital Européen George Pompidou, Assistance Publique-Hôpitaux de Paris, F75015 Paris, France; Service d'Endocrinologie (L.G.), Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, F75006 Paris, France; U693 (P.K., J.Y., S.B., P.C.), Institut National de la Santé et de la Recherche Médicale (INSERM), F-94276 Le Kremlin Bicêtre, France; Unité Mixte de Recherche 7371 and Unité Mixte de Recherche en Santé 1146 (A.R., N.K.), Laboratoire d'Imagerie Biomédicale, ICAN Imaging Core Lab, INSERM, F-75013 Paris, France.
Insights
Cushing's syndrome causes subclinical heart dysfunction in the left ventricle, right ventricle, and left atrium. Treatment of hypercortisolism reverses these cardiac issues, improving heart function.
Area of Science:
- Cardiology
- Endocrinology
- Cardiovascular Imaging
Background:
- Cushing's syndrome is linked to left ventricular hypertrophy and dysfunction.
- Echocardiography may be inaccurate in obese patients, and data on right ventricular and left atrial function are lacking.
Purpose of the Study:
- To evaluate left ventricular (LV), right ventricular (RV), and left atrial (LA) structure and function in Cushing's syndrome patients.
- Utilize cardiac magnetic resonance (CMR) as the reference standard for cardiac assessment.
Main Methods:
- Cardiac magnetic resonance (CMR) imaging of 18 Cushing's syndrome patients and 18 matched controls.
- Repeat CMR imaging 6 months post-treatment for hypercortisolism.
Main Results:
- Cushing's patients exhibited lower LV, RV, and LA ejection fractions and increased LV thickness compared to controls.
- Treatment improved LV ejection fraction by 15%, LA ejection fraction by 45%, and RV ejection fraction by 11%.
- LV mass index decreased by 17% post-treatment; no myocardial scarring was observed.
Conclusions:
- Cushing's syndrome is associated with reversible biventricular and left atrial systolic dysfunction.
- Increased LV mass in Cushing's syndrome patients is reversible after correcting hypercortisolism.
Background:
Patients with Cushing's syndrome have left ventricular (LV) hypertrophy and dysfunction on echocardiography, but echo-based measurements may have limited accuracy in obese patients. No data are available on right ventricular (RV) and left atrial (LA) size and function in these patients.
Objectives:
The objective of the study was to evaluate LV, RV, and LA structure and function in patients with Cushing's syndrome by means of cardiac magnetic resonance, currently the reference modality in assessment of cardiac geometry and function.
Methods:
Eighteen patients with active Cushing's syndrome and 18 volunteers matched for age, sex, and body mass index were studied by cardiac magnetic resonance. The imaging was repeated in the patients 6 months (range 2-12 mo) after the treatment of hypercortisolism.
Results:
Compared with controls, patients with Cushing's syndrome had lower LV, RV, and LA ejection fractions (P < .001 for all) and increased end-diastolic LV segmental thickness (P < .001). Treatment of hypercortisolism was associated with an improvement in ventricular and atrial systolic performance, as reflected by a 15% increase in the LV ejection fraction (P = .029), a 45% increase in the LA ejection fraction (P < .001), and an 11% increase in the RV ejection fraction (P = NS). After treatment, the LV mass index and end-diastolic LV mass to volume ratio decreased by 17% (P < .001) and 10% (P = .002), respectively. None of the patients had late gadolinium myocardial enhancement.
Conclusion:
Cushing's syndrome is associated with subclinical biventricular and LA systolic dysfunctions that are reversible after treatment. Despite skeletal muscle atrophy, Cushing's syndrome patients have an increased LV mass, reversible upon correction of hypercortisolism.
Related Concept Videos
Imaging Studies for Cardiovascular System IV: CMRI
Imaging Studies for Cardiovascular System V: CT
Cushing Syndrome II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Mitral Stenosis II: Clinical features and Diagnostic Tests
Cardiomyopathy IV: Restrictive Cardiomyopathy

